Preeti Lal

2.3k total citations · 1 hit paper
22 papers, 1.7k citations indexed

About

Preeti Lal is a scholar working on Surgery, Molecular Biology and Rheumatology. According to data from OpenAlex, Preeti Lal has authored 22 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Surgery, 4 papers in Molecular Biology and 4 papers in Rheumatology. Recurrent topics in Preeti Lal's work include Transplantation: Methods and Outcomes (4 papers), Asthma and respiratory diseases (4 papers) and Rheumatoid Arthritis Research and Therapies (4 papers). Preeti Lal is often cited by papers focused on Transplantation: Methods and Outcomes (4 papers), Asthma and respiratory diseases (4 papers) and Rheumatoid Arthritis Research and Therapies (4 papers). Preeti Lal collaborates with scholars based in United States, United Kingdom and Australia. Preeti Lal's co-authors include Joseph R. Arron, Sofia Mosesova, David F. Choy, Nicola A. Hanania, William W. Busse, Karin Rosén, Sally E. Wenzel, Hsin-Ju Hsieh, Jeffrey M. Harris and Brian Gabrielli and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Brain Research and Developmental Cell.

In The Last Decade

Preeti Lal

21 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Exploring the Effects of Omalizumab in Allergic Asthma

2013 669 citations Nicola A. Hanania, Sally E. Wenzel et al. American Journal of Respiratory and Critical Care Medicine profile →

Peers

Countries citing papers authored by Preeti Lal

Since Specialization

Citations

This map shows the geographic impact of Preeti Lal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Preeti Lal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Preeti Lal more than expected).

Fields of papers citing papers by Preeti Lal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Preeti Lal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Preeti Lal. The network helps show where Preeti Lal may publish in the future.

Co-authorship network of co-authors of Preeti Lal

This figure shows the co-authorship network connecting the top 25 collaborators of Preeti Lal. A scholar is included among the top collaborators of Preeti Lal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Preeti Lal. Preeti Lal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	POS1545 MODULATION OF SERUM BIOMARKERS IN PATIENTS WITH PSA TREATED WITH RISANKIZUMAB IN THE PHASE 3 KEEPSAKE 2 STUDY 2023 ·B Ravishankar, Preeti Lal, Thierry Sornasse, Boyuan Wang, Yingtao Bi, Mario Saltarelli, (unknown), (unknown), Joseph F. Merola, Oliver FitzGerald	1
2	1023P A novel microbiome-derived peptide, SG-3-00802 reverses resistance to anti-programmed death protein-1 (PD-1) therapy 2021 ·Annals of Oncology ·Helena Kiefel, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Erica Rutherford, Karim Dabbagh, Preeti Lal	1
3	Phase 1b Study of the Safety, Pharmacokinetics, and Disease-related Outcomes of the Matrix Metalloproteinase-9 Inhibitor Andecaliximab in Patients With Rheumatoid Arthritis 2017 ·Clinical Therapeutics ·David Gossage, (unknown), (unknown), Hao Zheng, Yan Xin, Preeti Lal, Guang Chen, Victoria Smith, John S. Sundy	43
4	Handoff mechanisms in LTE networks 2017 ·IOP Conference Series Materials Science and Engineering ·Preeti Lal, (unknown), (unknown)	2
5	Electronics Industry In India 2015 ·Preeti Lal	0
6	Exploring the Effects of Omalizumab in Allergic Asthma breakdown → 2013 ·American Journal of Respiratory and Critical Care Medicine ·Nicola A. Hanania, Sally E. Wenzel, Karin Rosén, Hsin-Ju Hsieh, Sofia Mosesova, David F. Choy, Preeti Lal, Joseph R. Arron, Jeffrey M. Harris, William W. Busse	669
7	Effect of baseline rheumatoid factor and anticitrullinated peptide antibody serotype on rituximab clinical response: a meta-analysis 2012 ·Annals of the Rheumatic Diseases ·John D. Isaacs, Stanley Cohen, Paul Emery, Paul P. Tak, Jianmei Wang, Guiyuan Lei, Sarah Williams, Preeti Lal, Simon Read	151
8	Lebrikizumab Treatment Reduces Serum Periostin Levels In Asthma Patients With Elevated Baseline Levels Of Periostin 2012 ·Heleen Scheerens, Joseph R. Arron, David F. Choy, Sofia Mosesova, Preeti Lal, John G. Matthews	9
9	Lebrikizumab reduces serum periostin in asthma patients with elevated baseline periostin 2012 ·Heleen Scheerens, Joseph R. Arron, David F. Choy, Sofia Mosesova, Preeti Lal, John G. Matthews	3
10	Lebrikizumab, An Anti-IL-13 Monoclonal Antibody, Reduces Severe Asthma Exacerbations Over 32 Weeks In Adults With Inadequately Controlled Asthma 2012 ·Dana McClintock, Jonathan Corren, Nicola A. Hanania, Sofia Mosesova, Preeti Lal, Joseph R. Arron, Mark D. Eisner, John G. Matthews	8
11	Inflammation and autoantibody markers identify rheumatoid arthritis patients with enhanced clinical benefit following rituximab treatment 2011 ·Arthritis & Rheumatism ·Preeti Lal, Zheng Su, Cécile Holweg, Gregg J. Silverman, Sergio Schwartzman, Ariella Kelman, Simon Read, (unknown), John G. Monroe, Timothy W. Behrens, Michael J. Townsend	54
12	A Plasmablast Biomarker for Nonresponse to Antibody Therapy to CD20 in Rheumatoid Arthritis 2011 ·Science Translational Medicine ·Kasia Owczarczyk, Preeti Lal, Alexander R. Abbas, Kristen Wolslegel, Cécile Holweg, Wolfgang Dummer, Ariella Kelman, Paul Brunetta, Nicholas Lewin‐Koh, Marco D. Sorani, Diane U. Leong, Paul J. Fielder, David E. Yocum, (unknown), Ward Ortmann, Michael J. Townsend, Timothy W. Behrens	64
13	Clinical Implications and Longitudinal Alteration of Peripheral Blood Transcriptional Signals Indicative of Future Cardiac Allograft Rejection 2008 ·The Journal of Heart and Lung Transplantation ·Mandeep R. Mehra, Jon Kobashigawa, Mario C. Deng, Kenneth C. Fang, Tod M. Klingler, Preeti Lal, Steven Rosenberg, Patricia A. Uber, Randall C. Starling, Srinivas Murali, Daniel Pauly, Russell L. Dedrick, Michael G. Walker, Adriana Zeevi, Howard J. Eisen	22
14	131: Gene expression and prediction of early cardiac allograft rejection: Discovery of a gene-based corticosteroid efficacy measure 2007 ·The Journal of Heart and Lung Transplantation ·Mandeep R. Mehra, Randall C. Starling, Preeti Lal, (unknown), Russell L. Dedrick, Steven Rosenberg	1
15	Transcriptional Signals of T-cell and Corticosteroid-sensitive Genes Are Associated With Future Acute Cellular Rejection in Cardiac Allografts 2007 ·The Journal of Heart and Lung Transplantation ·Mandeep R. Mehra, Jon Kobashigawa, Mario C. Deng, Kenneth C. Fang, Tod M. Klingler, Preeti Lal, Steven Rosenberg, Patricia A. Uber, Randall C. Starling, Srinivas Murali, Daniel Pauly, Russell L. Dedrick, Michael G. Walker, Adriana Zeevi, Howard J. Eisen	20
16	Cdk1/Erk2- and Plk1-Dependent Phosphorylation of a Centrosome Protein, Cep55, Is Required for Its Recruitment to Midbody and Cytokinesis 2005 ·Developmental Cell ·Megan Fabbro, Bin‐Bing S. Zhou, Mikiko Takahashi, Boris Šarčević, Preeti Lal, Mark E. Graham, Brian Gabrielli, Phillip J. Robinson, Erich A. Nigg, Yoshitaka Ono, Kum Kum Khanna	262
17	Noninvasive Discrimination of Rejection in Cardiac Allograft Recipients Using Gene Expression Profiling 2005 ·American Journal of Transplantation ·Mario C. Deng, Howard J. Eisen, Mandeep R. Mehra, Margaret E. Billingham, Charles C. Marboe, Gerald J. Berry, Jon Kobashigawa, F. L. Johnson, Randall C. Starling, S. Murali, Daniel Pauly, Helen Baron, Jay G. Wohlgemuth, R. Woodward, Tod M. Klingler, Dirk Walther, Preeti Lal, Steven Rosenberg, S. A. Hunt	361
18	Expression of glutamate uptake transporters after dibutyryl cyclic AMP differentiation and traumatic injury in cultured astrocytes 1997 ·Brain Research ·D L Eng, Yuen Ling Lee, Preeti Lal	33
19	Astrocyte-astrocytoma cell line interactions in culture 1996 ·Journal of Neuroscience Research ·Preeti Lal, Roopa S. Ghirnikar, Lawrence F. Eng	14
20	Astrocytoma and Schwann cells in coculture 1996 ·Molecular and Chemical Neuropathology ·Preeti Lal, Roopa S. Ghirnikar, Lawrence F. Eng	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact